|Description||(R)-(+)-HA-966 is a cell-permeable antagonist/partial agonist at the glycine site of the NMDA receptor.|
|Brife Description||NMDA receptor antagonist|
|Purity||≥98% by HPLC|
|Related CAS||111821-58-0 (S-enantiomer)|
TCN 237 dihydrochloride
TCN 237 dihydrochloride is a potent and NR2B-selective NMDA antagonist (Ki = 0.8 nM), blocks NR2B-mediated calcium influx in Ltk cells (Ki = 9.7 nM).
Homoquinolinic acid is a potent NMDA receptor agonist and neurotoxic agent.
Rapastinel, a brain penetrable tetrapeptide, could be a partial agonist of NMDA receptor. It was already finished the Phase II trial for acting as an antidepres...
MDL-29951 is a novel glycine antagonist of NMDA receptor activation, with Ki of 0.14 μM for [3H]glycine binding in vitro and in vivo.
NMDA is a specific agonist for NMDA receptor mimicking the action of glutamate, the neurotransmitter which normally acts at that receptor. Unlike glutamate, NM...
LY 233053 is an NMDA receptor antagonist with IC50 value of 7 nM.
ACBC has been found to be a NMDA receptor partial agonist and could probably affect the signal transmission in the CNS.
Besonprodil, a benzimidazolone bioisostere, is an NMDA antagonist that selective for the NR2B subunit.